500 related articles for article (PubMed ID: 31838891)
1. Present and Future Perspectives of Using Human-Induced Pluripotent Stem Cells and Organoid Against Liver Failure.
Kuse Y; Taniguchi H
Cell Transplant; 2019 Dec; 28(1_suppl):160S-165S. PubMed ID: 31838891
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration.
Messina A; Luce E; Hussein M; Dubart-Kupperschmitt A
Cells; 2020 Feb; 9(2):. PubMed ID: 32059501
[TBL] [Abstract][Full Text] [Related]
3. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
4. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC
Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine.
Deguchi S; Takayama K; Mizuguchi H
Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703
[TBL] [Abstract][Full Text] [Related]
6. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.
Asai A; Aihara E; Watson C; Mourya R; Mizuochi T; Shivakumar P; Phelan K; Mayhew C; Helmrath M; Takebe T; Wells J; Bezerra JA
Development; 2017 Mar; 144(6):1056-1064. PubMed ID: 28275009
[TBL] [Abstract][Full Text] [Related]
7. [The perspectives of hepatic failure treatment by stem cells].
Dolgikh MS
Biomed Khim; 2008; 54(4):376-91. PubMed ID: 18988455
[TBL] [Abstract][Full Text] [Related]
8. Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells.
Pettinato G; Lehoux S; Ramanathan R; Salem MM; He LX; Muse O; Flaumenhaft R; Thompson MT; Rouse EA; Cummings RD; Wen X; Fisher RA
Sci Rep; 2019 Jun; 9(1):8920. PubMed ID: 31222080
[TBL] [Abstract][Full Text] [Related]
9.
van den Berg CW; Koudijs A; Ritsma L; Rabelink TJ
J Am Soc Nephrol; 2020 May; 31(5):921-929. PubMed ID: 32354986
[TBL] [Abstract][Full Text] [Related]
10. Hepatic progenitor cells.
Sangan CB; Tosh D
Cell Tissue Res; 2010 Nov; 342(2):131-7. PubMed ID: 20957497
[TBL] [Abstract][Full Text] [Related]
11. [Culture of pluripotent stem cell-derived hepatocytes and organoids].
Zhu JY; Pei D
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):244-248. PubMed ID: 35462478
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a
Kruitwagen HS; Oosterhoff LA; van Wolferen ME; Chen C; Nantasanti Assawarachan S; Schneeberger K; Kummeling A; van Straten G; Akkerdaas IC; Vinke CR; van Steenbeek FG; van Bruggen LWL; Wolfswinkel J; Grinwis GCM; Fuchs SA; Gehart H; Geijsen N; Vries RG; Clevers H; Rothuizen J; Schotanus BA; Penning LC; Spee B
Cells; 2020 Feb; 9(2):. PubMed ID: 32053895
[TBL] [Abstract][Full Text] [Related]
13. Hybrid organoids consisting of extracellular matrix gel particles and hepatocytes for transplantation.
Ye J; Shirakigawa N; Ijima H
J Biosci Bioeng; 2015 Aug; 120(2):231-7. PubMed ID: 25660569
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte transplantation: waiting for stem cells.
Haridass D; Narain N; Ott M
Curr Opin Organ Transplant; 2008 Dec; 13(6):627-32. PubMed ID: 19060554
[TBL] [Abstract][Full Text] [Related]
15. Potentials of regenerative medicine for liver disease.
Ogawa S; Miyagawa S
Surg Today; 2009; 39(12):1019-25. PubMed ID: 19997795
[TBL] [Abstract][Full Text] [Related]
16. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.
Wang J; Sun M; Liu W; Li Y; Li M
Tissue Eng Regen Med; 2019 Apr; 16(2):107-118. PubMed ID: 30989038
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.
Tsuchida T; Murata S; Hasegawa S; Mikami S; Enosawa S; Hsu HC; Fukuda A; Okamoto S; Mori A; Matsuo M; Kawakatsu Y; Matsunari H; Nakano K; Nagashima H; Taniguchi H
Cell Transplant; 2020; 29():963689720964384. PubMed ID: 33103476
[TBL] [Abstract][Full Text] [Related]
18. Current status of stem cell therapy for liver diseases.
Souza BS; Nogueira RC; de Oliveira SA; de Freitas LA; Lyra LG; Ribeiro dos Santos R; Lyra AC; Soares MB
Cell Transplant; 2009; 18(12):1261-79. PubMed ID: 19660179
[TBL] [Abstract][Full Text] [Related]
19. Cell therapy for liver disease: From liver transplantation to cell factory.
Forbes SJ; Gupta S; Dhawan A
J Hepatol; 2015 Apr; 62(1 Suppl):S157-69. PubMed ID: 25920085
[TBL] [Abstract][Full Text] [Related]
20. Generation of hepatobiliary organoids from human induced pluripotent stem cells.
Wu F; Wu D; Ren Y; Huang Y; Feng B; Zhao N; Zhang T; Chen X; Chen S; Xu A
J Hepatol; 2019 Jun; 70(6):1145-1158. PubMed ID: 30630011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
